Tissue Factor Pathway Inhibitor and Other Endothelium-Dependent Hemostatic Factors in Elderly Individuals With Normal or Impaired Glucose Tolerance and Type 2 Diabetes
Open Access
- 1 August 2002
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (8) , 1340-1345
- https://doi.org/10.2337/diacare.25.8.1340
Abstract
OBJECTIVE—Impaired glucose tolerance (IGT) is believed to be a prediabetic phase that precedes the development of type 2 diabetes. In elderly subjects, IGT and diabetes are both independently associated with the occurrence of cardiovascular disease. Endothelial damage precedes atherosclerotic changes of the vascular wall. Therefore, several markers of endothelial dysfunction were examined in elderly subjects with IGT and elderly patients with type 2 diabetes. RESEARCH DESIGN AND METHODS—Von Willebrand factor (vWF), tissue plasminogen activator (t-PA), plasminogen activator inhibitor type-1 (PAI-1), and thrombomodulin were studied as markers of endothelial dysfunction in a population-based study of elderly subjects with normal glucose tolerance (NGT) or IGT and type 2 diabetes. In addition to these endothelium-dependent factors, we also investigated tissue factor pathway inhibitor (TFPI) activity in relation to metabolic parameters and cardiovascular risk factors. RESULTS—All data were adjusted for age. Increased levels of vWF antigen, t-PA antigen, and PAI-1 activity were seen in the IGT and diabetic group compared with the NGT group. TFPI activity and thrombomodulin levels were increased in all elderly subjects, and no differences were seen between the groups. There was a positive association between HbA1c and TFPI activity and vWF antigen. Fasting blood glucose levels correlated with vWF antigen, t-PA antigen, and PAI-1 activity, whereas urine albumin excretion correlated with TFPI activity, vWF antigen, and PAI-1 activity. Serum insulin levels correlated strongly not only with vWF antigen and t-PA antigen but also with PAI-1 activity. This correlation did not change after further adjustment for serum glucose and HbA1c, which may suggest that in the elderly subjects, impaired fibrinolysis is probably associated with insulin resistance. There were no associations between the endothelium-dependent hemostatic factors and lipids, except for a negative correlation between HDL cholesterol and thrombomodulin. CONCLUSIONS—In elderly subjects with IGT, several endothelium-dependent hemostatic factors are already consistently increased, indicating endothelial damage in this stage.Keywords
This publication has 40 references indexed in Scilit:
- Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factorExperimental and Clinical Endocrinology & Diabetes, 2001
- Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With MicroalbuminuriaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The increase with age of the components of the tissue factor coagulation pathway is gender-dependentBlood Coagulation & Fibrinolysis, 1995
- Tissue factor pathway inhibitor activity in patients with IDDMDiabetes, 1995
- Decreased Plasminogen Activator Inhibitor‐1 Activity in Newly Diagnosed Type 2 Diabetic Patients Following Dietary ModificationDiabetic Medicine, 1993
- A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDMDiabetes Care, 1993
- The present status of tissue factor pathway inhibitorBlood Coagulation & Fibrinolysis, 1992
- Asymptomatic Hyperglycemia and Atherosclerotic Vascular Disease in the ElderlyDiabetes Care, 1992
- Factors of the Hemostatic System in Diabetic PatientsPathophysiology of Haemostasis and Thrombosis, 1986
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Circulation, 1983